Novel specific activity-based probes validate KLK proteases as druggable targets

por Sotiropoulou, Georgia, Zingkou, Eleni, Pampalakis, Georgios
Publicado 2022

Kallikreins emerge as new regulators of viral infections

por Pampalakis, Georgios, Zingkou, Eleni, Panagiotidis, Christos, Sotiropoulou, Georgia
Publicado 2021

Activity-Based Probes for Proteases Pave the Way to Theranostic Applications

por Sotiropoulou, Georgia, Zingkou, Eleni, Bisyris, Evangelos, Pampalakis, Georgios
Publicado 2022

A chemogenomic approach is required for effective treatment of amyotrophic lateral sclerosis

por Pampalakis, Georgios, Angelis, Georgios, Zingkou, Eleni, Vekrellis, Kostas, Sotiropoulou, Georgia
Publicado 2022

Biochemical pathways mediated by KLK6 protease in breast cancer

por Pampalakis, Georgios, Zingkou, Eleni, Sidiropoulos, Konstantinos Gus, Diamandis, Eleftherios P., Zoumpourlis, Vassilis, Yousef, George M., Sotiropoulou, Georgia
Publicado 2019

Treatment of keratinocytes with 4-phenylbutyrate in epidermolysis bullosa: Lessons for therapies in keratin disorders

por Spörrer, Marina, Prochnicki, Ania, Tölle, Regine C., Nyström, Alexander, Esser, Philipp R., Homberg, Melanie, Athanasiou, Ioannis, Zingkou, Eleni, Schilling, Achim, Gerum, Richard, Thievessen, Ingo, Winter, Lilli, Bruckner-Tuderman, Leena, Fabry, Ben, Magin, Thomas M., Dengjel, Jörn, Schröder, Rolf, Kiritsi, Dimitra
Publicado 2019